药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02269 药明生物

已收盘 05-19 16:08:20

33.000

+0.060

+0.18%

最高33.640	最低32.680	成交量1,737万
今开32.680	昨收32.940	日振幅2.91%
总市值1,367亿	流通市值1,367亿	总股本41.41亿
成交额5.74亿	换手率0.42%	流通股本41.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":33,"timestamp":1779178100005,"preClose":32.94,"halted":0,"volume":17366804,"delay":0,"changeRate":0.0018214936247723825,"floatShares":4140999999,"shares":4140999999,"eps":1.3352075444299107,"marketStatus":"已收盘","change":0.06,"latestTime":"05-19 16:08:20","open":32.68,"high":33.64,"low":32.68,"amount":573910047,"amplitude":0.029144,"askPrice":33,"askSize":159500,"bidPrice":32.98,"bidSize":14000,"shortable":3,"etf":0,"ttmEps":1.3352075444299107,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":32.94,"openAndCloseTimeList":[[1779154200000,1779163200000],[1779166800000,1779177600000]],"volumeRatio":0.60126,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.3852,"impliedVolPercentile":0.0891},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"1129797493","title":"药明生物拟回购不超过已发行股本10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1129797493","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129797493?lang=zh_cn&edition=full","pubTime":"2026-05-19 16:36","pubTimestamp":1779179800,"startTime":"0","endTime":"0","summary":"药明生物于2026年5月19日发布公告，董事会建议授予一般性授权，可在股东大会通过后，于香港联合交易所有限公司等合规市场购回公司不超过提案表决当日已发行股份总数10%的股份。以2026年5月13日的实际可行日期为基准，公司已发行股份约为4,140,831,636股，回购数量上限约为414,083,163股。公司指出，除董事会认为必要的情况下，不会进行在财务或营运上可能产生重大不利影响的回购操作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物拟回购不超过已发行股本10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636030884","title":"【券商聚焦】招银国际：AI有望改变创新药研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2636030884","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636030884?lang=zh_cn&edition=full","pubTime":"2026-05-19 13:13","pubTimestamp":1779167581,"startTime":"0","endTime":"0","summary":"当前，监管框架持续完善，传统药企与AI原生公司加速合作，AI制药正处于从研发提效工具迈向创新药研发范式重构的转折期。AI重构药物研发全链条，早期效率红利已率先显现。传统创新药研发长期受困于高成本、长周期和低成功率，AI技术正在改变靶点发现、分子筛选与优化等关键环节的研发范式。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981743","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU0315179316.USD","LU1226288170.HKD","02142","LU0348767384.USD","LU1719994722.HKD","01177","LU0140636845.USD","01801","CHAT","02616","LU1960683339.HKD","09995","LU1152091168.USD","IE00B031HY20.USD","BK1588","LU0067412154.USD","LU0456827905.SGD","LU0072913022.USD","LU0634319403.HKD","LU0456846285.SGD","LU0561508036.HKD","ARTY","LU2097828631.EUR","AIPO","09926","06185","BK1589","LU0856984785.SGD","LU1993786604.SGD","09688","06160","LU1303224171.USD","BK1161","LU0572944931.SGD","06978","159992","BK1583","01877","LU0417516738.SGD","LU1880383366.USD","02269","LU1226287792.SGD","LU1152091754.HKD","AGIX","SG9999002562.SGD","LU0516422952.EUR","IE00BPRC5H50.USD","LU0326950275.SGD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","HK0000320264.USD","399441","LU0307460666.USD","02268","SG9999014674.SGD","LU0417516902.SGD","LU1719994722.HKD","LU0052750758.USD","XBI","BK1574","01548","BK4588","LU1242518931.SGD","06990","BK1588","LU1688375341.USD","LU0456846285.SGD","LU0359201612.USD","LU0359202008.SGD","LU1770034418.SGD","LU0823426308.USD","LU0043850808.USD","09969","161726","BK1589","LU0516422366.SGD","LU1251922891.USD","06160","LU1303224171.USD","BK1161","BK1583","688235","LU0417516738.SGD","LU0320764599.SGD","02269","LU0181495838.USD","ONC","IE00B0JY6N72.USD","HK0000306701.USD","BK1576","SG9999002562.SGD","LU0708995583.HKD","LU0039217434.USD","LU0516422440.USD","BK1141","LU0348825331.USD","LU3063872942.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636483820","title":"【券商聚焦】中信建投：创新药迎盈利兑现期 国内商业化与海外授权双轮驱动业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2636483820","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636483820?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:32","pubTimestamp":1779067963,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，2026年上半年医药行业触底回暖，创新药迎来盈利兑现期，国内商业化与海外授权双轮驱动业绩增长，多家企业扭亏。26Q1对外授权总额超600亿美元，ADC、双抗等前沿赛道交易持续火热。2026年ASCO年会94项中国研究中选口头报告，依沃西单抗登上全体大会，标志着中国创新药全球学术影响力迈上新台阶。国内支付端医保谈判与商保目录合力支持真创新。建议关注创新药国际化、边际改善等结构性机会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981512","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","01877","01093","SG9999002562.SGD","LU1242518857.USD","LU1152091168.USD","LU1688375341.USD","IE00B5MMRT66.SGD","LU1993786604.SGD","LU0417516738.SGD","06185","09688","06978","BK1588","LU0588546209.SGD","BK1574","LU1969619763.USD","LU0979878070.USD","LU0516422952.EUR","LU0456827905.SGD","LU2097828631.EUR","LU0348827113.USD","LU0561508036.HKD","601066","IE00BZ08YS42.EUR","IE00B0JY6N72.USD","02269","09926","LU0516423174.USD","LU1303224171.USD","LU2097828557.USD","02616","LU0039217434.USD","01177","09995","LU1152091754.HKD","02142","IE00BZ08YR35.GBP","BK1161","BK1141","LU0359202008.SGD","159992","LU2399975544.HKD","LU1226287875.USD","LU0326950275.SGD","IE00BZ08YT58.USD","LU1242518931.SGD","LU2097828474.EUR","01801","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635989704","title":"港股三大指数全日持续走低 恒指跌1.62% 长飞光纤光缆(06869)跌12.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635989704","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635989704?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:18","pubTimestamp":1778833085,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数全日持续走低，午后跌幅扩大，截至收盘，恒指跌1.62%，恒科指跌2.66%，国企指数跌1.89%。跌幅方面，京东健康跌6.62%，中国宏桥跌5.92%，洛阳钼业跌5.75%。消息面上，沪银主力合约日内暴跌10.00%，现报19422.00元/千克。汇聚科技  跌1.81%，鸿腾精密  跌5.72%，剑桥科技  跌7.32%，曦智科技P  跌9.06%，华虹半导体  跌8.74%，长飞光纤光缆  跌12.14%。宏观上，星展预计香港楼价今年升10%，渣打上调香港2026年GDP增速至4.3%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981476","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU0228659784.USD","IE0008369823.USD","VXUS","LU0043850808.USD","BK1618","02269","LU1282648689.USD","LU0326948709.USD","LU1328277881.USD","03690","MPNGY","BK1604","METmain","MHImain","LU1719994722.HKD","LU0047713382.USD","LU0417516902.SGD","LU1961090484.USD","06618","513600","HSImain","LU1224709979.USD","LU0577902538.SGD","LU1868837722.USD","02692","HHImain","BK1576","HMTD.SI","LU0516423091.SGD","LU0737861699.HKD","00300","LU0210526637.USD","LU0880133367.SGD","LU0261950983.USD","86618","LU1251922891.USD","LU2097828631.EUR","SG9999000327.SGD","SG9999000459.SGD","LU0211977185.USD","LU0797268264.HKD","BK1142","LU0979878070.USD","02833","HSI","LU0348814723.USD","LU0196878994.USD","06869","MCHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635033367","title":"恒生科技走低，腾讯控股、药明生物逆市飘红","url":"https://stock-news.laohu8.com/highlight/detail?id=2635033367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635033367?lang=zh_cn&edition=full","pubTime":"2026-05-15 14:31","pubTimestamp":1778826703,"startTime":"0","endTime":"0","summary":"5月15日午后，恒生科技走低，跌超3%；成分股中，腾讯控股、药明生物逆市飘红。消息面上，5月13日，腾讯控股发布2026年第一季度财报。受益于AI战略加速，腾讯一季度营收1964.6亿元，同比增长9%；Non-IFRS经营利润756.3亿元，同比增长9%。国证港股通科技指数汇聚港股特色科技资产，覆盖硬科技+互联网+生物科技，受益于AI产业趋势、“十五五”制造升级与科技自立自强、创新药出海浪潮。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026051500021486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0084288322.USD","LU0289960550.SGD","LU0593848301.USD","IE00BQXX3F31.USD","BK1576","LU1303224171.USD","LU0594300179.USD","LU2097828631.EUR","LU1769817096.USD","LU0326950275.SGD","LU1956131251.USD","IE0008368411.USD","SG9999018865.SGD","LU1188198961.HKD","LU1152091168.USD","LU0261950983.USD","LU0463099449.HKD","LU1224709979.USD","LU1008478684.HKD","SG9999014674.SGD","LU0061477393.USD","LU1504937902.USD","LU0327786744.USD","LU1813983027.USD","LU2097828714.EUR","LU0348814723.USD","LU1282651048.USD","SGXZ31699556.SGD","LU0345769631.USD","LU2045819591.USD","LU0417516902.SGD","LU1282651121.HKD","LU0348783662.USD","LU0577902371.SGD","LU0786609619.USD","LU2125910849.SGD","LU2293587155.HKD","LU0328353924.USD","LU0251144936.SGD","LU1196710351.USD","LU0633140727.USD","LU2362540622.SGD","LU1023057109.AUD","BK1526","LU2362541513.USD","LU0164880469.USD","LU2476274720.SGD","IE00B8L5B284.USD","LU0823040885.USD","HK0001040168.HKD","LU0165289439.USD","LU0642271901.SGD","IE00B543WZ88.USD","LU1868837565.USD","LU0192582467.USD","SG9999014906.USD","LU0173614495.USD","IE00B0JY6N72.USD","LU1733274473.HKD","LU2362541273.HKD","IE00BF5LJ272.USD","IE00B067MR52.USD","IE00BPRC5H50.USD","LU0235996351.USD","LU0831103253.SGD","LU1282649067.USD","LU0577902538.SGD","LU0499858602.USD","LU0561508036.HKD","LU2251237488.HKD","LU1868838027.USD","LU0456842615.SGD","LU0784639295.USD","LU1769817179.HKD","LU0431992006.USD","LU0348816934.USD","LU0918141887.USD","LU0067412154.USD","LU0345775950.USD","LU0149534421.HKD","LU1251922891.USD","LU0828237510.HKD","LU1044874839.SGD","LU0315179316.USD","LU0509642566.USD","LU1880383366.USD","LU0577902298.EUR","LU0047713382.USD","IE00B3M56506.USD","LU1046422090.SGD","SG9999014898.SGD","LU0577902611.USD","LU1051769294.HKD","LU1328615791.USD","LU0244354667.USD","LU0856984785.SGD","SG9999001093.SGD","LU1481107354.HKD","LU2023250504.SGD","IE0003895053.USD","LU0143863198.USD","LU2317271919.USD","LU0862451753.SGD","LU0203345920.USD","IE0031814852.USD","LU1720050803.USD","IE0001KFT4U8.USD","LU0345776255.USD","LU0823041008.USD","IE0008369823.USD","LU0210526637.USD","LU0648948544.HKD","BK1591","LU0348783233.USD","LU1226288170.HKD","LU0348788117.USD","LU1064130708.USD","LU0254981946.USD","LU1439103000.SGD","HK0000151867.HKD","LU0918141705.HKD","BK1586","LU0048580855.USD","LU0516422366.SGD","IE0008368742.USD","IE00BQXX3C00.GBP","LU2125910500.SGD","LU0572944931.SGD","LU0128522157.USD","LU0106259558.USD","LU0117844026.USD","LU0605514214.HKD","SG9999001846.SGD","LU1316542783.SGD","LU2237443549.SGD","LU1917777945.USD","LU2476274308.USD","LU1226287792.SGD","LU0488056044.USD","IE00B5MMRT66.SGD","LU0611395673.USD","LU0502904849.HKD","BK1589","LU0823426308.USD","LU2097828474.EUR","SG9999002463.SGD","LU2237443622.USD","LU0314109678.HKD","LU0051755006.USD","LU2148510915.USD","IE00B8HQ1Z84.USD","LU0348825331.USD","LU0823413660.USD","LU0594300419.USD","LU0048388663.USD","SG9999018857.SGD","LU1242518931.SGD","HK0000320264.USD","LU0823039010.USD","LU0345769128.USD","LU0348784397.USD","LU1226288253.USD","LU0819121731.USD","LU0261947096.USD","SG9999001226.SGD","LU1048484197.HKD","LU0823413587.USD","LU0417516738.SGD","LU0588545730.USD","LU0029875118.USD","LU0878005551.USD","LU1785774172.SGD","LU0608807433.USD","LU2177674079.SGD","IE0003851619.USD","LU1675838814.USD","SG9999001903.USD","LU0029874905.USD","LU0132412106.USD","LU0320764243.SGD","LU1044876610.USD","LU0293314216.USD","SG9999001069.SGD","00700","LU0140636845.USD","LU1981816686.USD","SG9999001689.USD","LU1807302812.USD","LU0080751232.USD","LU0287142896.SGD","LU1804176565.USD","HK0000306701.USD","LU2251237306.USD","LU0359201885.HKD","LU2237443895.HKD","SG9999001051.SGD","LU2778985437.USD","BK1502","GB00BDT5M118.USD","LU0231483743.USD","LU1282648689.USD","LU0049112450.USD","SG9999000459.SGD","IE00B97KM107.HKD","SG9999006514.SGD","LU1718418525.SGD","LU2106854487.HKD","WXXWY","LU2039709279.SGD","LU2237443465.HKD","LU0708995583.HKD","IE00B031HW06.USD","LU0455707207.USD","SGXZ51526630.SGD","IE00BZ08YT58.USD","LU0070217475.USD","LU0211331839.USD","BK1531","LU0149721374.USD","LU1951186391.HKD","LU0823038988.USD","SG9999015945.SGD","LU0315178854.USD","LU0329678170.USD","LU0607220059.USD","LU2237443382.USD","LU0541502299.USD","LU1770036033.HKD","LU1366334651.USD","LU0214875030.USD","LU0541501648.USD","LU2498475776.HKD","LU0359201612.USD","LU0862451837.USD","LU0143863784.USD","LU0675040207.SGD","LU0164872284.USD","LU2152927971.USD","LU0865486749.SGD","SG9999003461.SGD","LU2265009873.SGD","LU0469268626.HKD","IE0034224299.USD","LU0169518387.USD","LU1814569148.SGD","LU0608807946.USD","LU0348723411.USD","LU0828237940.HKD","HK0001040143.USD","LU0196878994.USD","SGXZ81514606.USD","LU0228367735.SGD","SG9999015952.SGD","LU0588545490.SGD","LU2294711473.HKD","LU1366334578.USD","LU1883866441.USD","LU0501845795.SGD","LU0791591158.USD","SG9999015978.USD","LU0972618739.USD","LU2257852520.SGD","LU0417516571.SGD","LU0164865239.USD","LU0572940350.SGD","BK1141","SG9999015986.USD","LU0871576103.HKD","IE00BQXX3D17.EUR","LU0048597586.USD","BK1095","LU0106252389.USD","IE00B29SXG58.USD","LU0979878070.USD","TCEHY","LU0264606111.USD","LU1105468828.SGD","LU2279701549.SGD","SG9999014880.SGD","LU1211504680.USD","IE00BZ08YR35.GBP","LU0039217434.USD","HK0000306685.HKD","LU1794554557.SGD","LU0175139822.USD","LU1328277881.USD","HK0000914686.HKD","LU0797268264.HKD","LU0589944569.HKD","LU0329678337.USD","LU3063872942.SGD","LU0633140560.USD","LU0370786039.SGD","LU1048596156.SGD","LU0348735423.USD","LU0985320562.USD","LU0210533765.USD","BK1521","LU0229945570.USD","LU1734074674.USD","LU0878004406.USD","LU0540923850.HKD","LU0828238088.HKD","LU1226287875.USD","SG9999000418.SGD","LU1691799644.USD","LU0700851271.USD","LU0588545904.SGD","LU0052750758.USD","LU0456846285.SGD","LU0307460666.USD","LU2133065610.SGD","LU1064131003.USD","LU0650527681.SGD","LU0737861772.HKD","LU0259732245.USD","LU0096374516.USD","LU0107464264.USD","LU0054237671.USD","LU1960683339.HKD","LU2462611646.USD","LU1196710864.SGD","LU1770034418.SGD","LU1102505929.USD","LU0634319403.HKD","LU0348805143.USD","SG9999002562.SGD","LU0516422440.USD","LU0117841782.USD","LU1196710195.USD","LU0188438112.USD","LU0203347892.USD","LU0823397103.USD","LU1439102457.SGD","SG9999007991.SGD","LU0823426480.USD","LU0821914370.USD","IE0009570106.USD","02269","LU0577902454.USD","LU0531970944.HKD","LU2449936058.SGD","SG9999004220.SGD","LU0449509016.USD","LU1810669033.SGD","LU1282649141.HKD","LU0651946864.USD","LU0890818403.SGD","SG9999006597.SGD","LU0819123356.HKD","LU2051468812.USD","BK1618","LU0414403682.SGD","BK1609","LU0791590937.USD","LU2008162690.USD","HK0000352382.USD","LU0823397285.USD","LU2237443978.SGD","LU1568876251.USD","LU0672654166.SGD","LU0181495838.USD","LU0516423174.USD","LU1102505762.USD","LU1152091754.HKD","IE0003795394.USD","LU2242644610.SGD","LU0873338254.USD","LU1719994722.HKD","IE00B031J352.USD","IE00B031HY20.USD","LU0543330483.HKD","LU0456827905.SGD","LU1226287529.USD","LU0128522744.USD","SGXZ99366536.SGD","LU1993786604.SGD","LU1868837722.USD","LU0886674414.USD","LU1880383440.USD","SG9999000327.SGD","LU0543330566.HKD","LU0396098781.USD","LU1961090484.USD","SG9999017495.SGD","SG9999014914.USD","LU0737861699.HKD","LU1515016050.SGD","LU0210527791.USD","LU0348827113.USD","LU2087589342.USD","LU0054450605.USD","LU1688375341.USD","LU1051768304.USD","LU0106959298.USD","LU0572939691.SGD","LU0499858438.USD","LU0738912210.USD","BK1615","LU1642822792.SGD","LU1733274390.USD","LU0011963245.USD","SG9999002828.SGD","LU0072462343.USD","LU0359202008.SGD","HK0000352291.HKD","IE00BZ08YS42.EUR","LU1568876335.HKD","LU1226288097.SGD","LU0269904917.USD","LU0072913022.USD","IE00B0169N27.USD","LU1725190679.HKD","LU0228659784.USD","LU0049853897.USD","LU0516423091.SGD","LU1044875133.USD","LU0588546209.SGD","LU1831875114.USD","LU1282649810.SGD","BK1516","LU1974910355.USD","LU0531971595.HKD","LU0441854154.USD","LU2399975544.HKD","SGXZ90724238.SGD","LU0708995153.HKD","LU2247934214.USD","LU0320764599.SGD","LU1323998911.USD","LU0683595622.HKD","IE0032431581.USD","LU0868486357.SGD","LU2097828557.USD","IE00BGV7N243.SGD","LU0898667661.SGD","LU0127658192.USD","LU1242518857.USD","LU2097828805.USD","LU0326948709.USD","LU0449515922.USD","HTCD.SI","LU0320764755.SGD","BK1608","BK1610","LU1629966141.USD","BK1517","LU0880133367.SGD","LU0384037296.USD","LU1235295612.USD","LU0516422952.EUR","LU1808992512.USD","SG9999013353.USD","HK0000320223.HKD","IE00B0169L03.USD","HK0000914660.USD","LU0043850808.USD","LU0651947912.USD","LU1224444064.USD","LU2226246903.HKD","IE0032834883.USD","LU0163747925.USD","LU0882747503.HKD","LU1655091459.SGD","LU0211977185.USD","LU1048588211.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634015154","title":"花旗：中国医疗保健行业基本面持续改善 首选药明康德(02359)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2634015154","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634015154?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:54","pubTimestamp":1778489665,"startTime":"0","endTime":"0","summary":"创新正获得回报，授权交易预付款及里程碑付款带动盈利，创新药销售加速，而CXO订单量更创下历史新高。展望未来，该行预期将有一系列短期催化剂，包括ASCO 2026年数据发布、授权交易势头持续、4月14日药品价格改革后续、CXO指引可能上调，以及市场整合加速利好医疗科技、服务及药房领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572944931.SGD","01093","01276","LU2045819591.USD","LU0315179316.USD","LU0516423174.USD","IE0008369823.USD","LU0516422366.SGD","BK1515","BK1141","BK1191","02269","LU0072461881.USD","IE00BZ08YT58.USD","LU1951186391.HKD","SG9999004220.SGD","LU0314109678.HKD","LU1023057109.AUD","LU1226288253.USD","LU1506573853.SGD","LU2242644610.SGD","LU0980610538.SGD","01672","LU1719994722.HKD","02359","LU2097828714.EUR","LU2488822045.USD","LU1242518857.USD","LU0979878070.USD","LU2125154935.USD","IE00B031HY20.USD","LU1226287792.SGD","LU0326950275.SGD","LU1997245177.USD","LU0310800965.SGD","LU0455707207.USD","LU1366192091.USD","IE00B5MMRT66.SGD","LU0098860793.USD","LU0203347892.USD","603259","LU0359202008.SGD","LU0307460666.USD","LU1997244956.HKD","LU0170899867.USD","01801","BK4504","LU2417539215.USD","LU1008478684.HKD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131060708","title":"药明生物公布2026年4月股份变动月报，股本增至4,140,823,636股","url":"https://stock-news.laohu8.com/highlight/detail?id=1131060708","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131060708?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:21","pubTimestamp":1778163699,"startTime":"0","endTime":"0","summary":"2026年5月7日，药明生物发布截至2026年4月30日的股份变动月报。公告显示，公司本月内法定注册股本保持不变，仍为6,000,000,000股普通股，每股面值为USD 0.000008333333，总注册股本维持在USD 50,000。截至本月底，公司已发行普通股总数增至4,140,823,636股。公告显示，药明生物本月因行使多笔首次公开发售前购股权计划共发行新股3,030,200股，涉及募集资金总额USD 1,014,064.84。此外，药明生物表示已严格遵守包括监管部门及香港联交所《上市规则》在内的所有适用要求。公告由董事陈智胜签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633978001","title":"2025年A股高管薪酬排行榜：药明康德CEO李革近4000万元年薪高居榜首，千万元年薪高管超30人","url":"https://stock-news.laohu8.com/highlight/detail?id=2633978001","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633978001?lang=zh_cn&edition=full","pubTime":"2026-05-07 14:26","pubTimestamp":1778135178,"startTime":"0","endTime":"0","summary":"随着A股2025年报披露收官，上市公司高管年薪随之浮出水面。哪些行业上市公司高管薪酬位居前列？哪家公司高管薪酬涨幅最大？谁薪酬最高？金融业人均薪酬位居前茅从行业维度来看，申万31个一级行业中，银行业上市公司高管薪酬水平位居榜首，非银金融排名第二，美容护理位居第三，电子、医药生物行业进入前五。此外，有色金属、家用电器、电力设备、石油石化、交通运输、汽车等行业排名靠前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073729982450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1251922891.USD","LU0456846285.SGD","LU0516422366.SGD","LU0708995583.HKD","LU2488822045.USD","LU1720050803.USD","LU1969619763.USD","LU0348825331.USD","LU0572944931.SGD","BK1141","LU0359201612.USD","LU1719994722.HKD","LU1242518857.USD","LU1997245177.USD","BK1576","LU1997245094.SGD","SG9999002562.SGD","LU1303224171.USD","LU0052750758.USD","LU1688375341.USD","BK1521","IE00B0JY6N72.USD","LU1880383366.USD","LU0819121731.USD","LU0307460666.USD","LU0456827905.SGD","LU0979878070.USD","LU0823426308.USD","BK1589","LU0516422952.EUR","LU0039217434.USD","LU1242518931.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0140636845.USD","02269","LU1934453819.USD","LU0588546209.SGD","LU0043850808.USD","399300","02359","LU0326950275.SGD","LU3063872942.SGD","603259","LU0856984785.SGD","159982","LU0327786744.USD","LU1770034418.SGD","LU1794554557.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131242383","title":"异动解读 | 药明生物盘中大涨5.08%，年报业绩强劲及积极指引提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1131242383","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131242383?lang=zh_cn&edition=full","pubTime":"2026-05-04 11:10","pubTimestamp":1777864228,"startTime":"0","endTime":"0","summary":"药明生物今日盘中股价大幅上涨5.08%，引起了市场的广泛关注。消息面上，公司近日披露了年度报告，业绩表现十分强劲。数据显示，公司全年实现收入约217.9亿元人民币，同比增长16.7%；毛利约100.19亿元，同比增长30.9%，毛利率显著提升；归属公司拥有人净利润约56.4亿元，同比增长17.9%。此外，基于强劲的增长势头和在手订单，公司给出了积极的业绩指引，预计未来收入将实现13%-17%的同比增长，盈利可见度较高。这些利好消息显著提振了市场情绪和投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137205364","title":"药明生物（02269）2025年收入与盈余强劲增长，项目储备与合规实力显著提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1137205364","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137205364?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:42","pubTimestamp":1777452131,"startTime":"0","endTime":"0","summary":"药明生物于2025年度实现收入21,790,018千元人民币，较2024年度的18,675,371千元人民币增长16.7%。报告期内，公司综合财务指标整体向好：毛利由7,650,820千元人民币上升至10,018,512千元人民币，同比增幅达30.9%，毛利率从41.0%提升至46.0%。经营活动产生的现金流净额为63.41亿元人民币，较2024年度的52.17亿元人民币增长21.46%。其中，归属于公司拥有人应占净利润为5,640,299千元人民币，对比2024年度4,784,130千元人民币增长17.9%。此外，除税前溢利上升至7,256,907千元人民币，升幅为50.1%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物（02269）2025年收入与盈余强劲增长，项目储备与合规实力显著提升","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2630077463","title":"药明康德(02359)重选李革为董事会董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2630077463","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630077463?lang=zh_cn&edition=full","pubTime":"2026-04-28 21:14","pubTimestamp":1777382066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德 发布公告，董事会审议并批准重选李革博士为第四届董事会董事长，自2026年4月28 日起，至第四届董事会任期届满之日止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","LU0823426308.USD","IE00B0JY6N72.USD","LU0140636845.USD","LU1808992512.USD","LU0516422952.EUR","LU0856984785.SGD","BK0216","BK1521","BK1583","02269","LU1688375341.USD","LU0456846285.SGD","LU1242518857.USD","LU0348825331.USD","BK1576","LU3063872942.SGD","SG9999002463.SGD","LU0359202008.SGD","LU2495084118.USD","BK1610","LU0708995583.HKD","LU0307460666.USD","LU0051755006.USD","LU0326950275.SGD","LU1997245177.USD","LU0320764599.SGD","LU0327786744.USD","LU2328871848.SGD","LU1880383366.USD","LU1997245094.SGD","LU0348767384.USD","LU0456827905.SGD","LU0516422440.USD","LU1969619763.USD","LU1997244956.HKD","LU0516423174.USD","LU1720050803.USD","LU0516423091.SGD","BK1141","LU2125910500.SGD","LU2242644610.SGD","LU0359201612.USD","603259","LU0039217434.USD","LU0348735423.USD","02359","LU0417516902.SGD","LU2039709279.SGD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102979103","title":"异动解读 | 行业板块普涨带动，药明生物盘中大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102979103","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102979103?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:46","pubTimestamp":1777340789,"startTime":"0","endTime":"0","summary":"药明生物今日盘中股价大幅上涨，涨幅达到5.17%，表现强劲。消息面上，药明生物所在的整个生命科学工具与服务行业今日普遍走强，形成了显著的板块效应，这被认为是推动其股价上涨的主要因素。行业内的多家公司，如药明康德、药明合联、康龙化成等，在同期均录得可观涨幅，显示出市场对该板块的关注度与投资热情有所提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629077324","title":"药明生物获韩国MFDS GMP认证 助力双抗生物药商业化生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2629077324","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629077324?lang=zh_cn&edition=full","pubTime":"2026-04-23 08:57","pubTimestamp":1776905879,"startTime":"0","endTime":"0","summary":"药明生物宣布，其位于无锡的三家生产厂生物药原液五厂（MFG5）、生物药制剂二厂（DP2）以及制剂包装中心（DPPC），已获韩国食品药品安全部（MFDS）GMP认证，为一款用于胆道肿瘤治疗的双特异性抗体提供涵盖原液和制剂的端到端商业化生产服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604233715266732.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233715266732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0979878070.USD","LU0052750758.USD","BK1610","SG9999002463.SGD","LU1242518857.USD","BK1141","BK1576","LU0326950275.SGD","LU3063872942.SGD","LU0348735423.USD","LU0856984785.SGD","SG9999002562.SGD","LU1794554557.SGD","BK1521","LU0708995583.HKD","LU0823426480.USD","LU0588546209.SGD","LU1880383366.USD","159839","LU0051755006.USD","LU0043850808.USD","LU0327786744.USD","BK1589","LU0516423174.USD","LU1242518931.SGD","LU0516422366.SGD","LU0320764599.SGD","LU1720050803.USD","LU0307460666.USD","LU0181495838.USD","LU0516423091.SGD","LU0823426308.USD","LU1688375341.USD","02269","LU0417516902.SGD","LU0572944931.SGD","LU0140636845.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0348825331.USD","LU0516422952.EUR","LU0819121731.USD","LU0039217434.USD","LU0456846285.SGD","LU0359202008.SGD","LU0516422440.USD","LU0417516738.SGD","LU2039709279.SGD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628799412","title":"迈威生物-B(02493)今起招股 君实生物、桂林三金及药明生物等基石认购5300万美元发售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628799412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628799412?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:34","pubTimestamp":1776638067,"startTime":"0","endTime":"0","summary":"2025年8月，迈利舒及迈卫健获巴基斯坦药品监管局上市批准。迈利舒及迈卫健是在巴基斯坦获批的首个Prolia及Xgeva生物类似药。于2024年及2025年，净亏损分别为约10.47亿元及9.72亿元，主要由于研发活动所产生的成本及开支。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688180","BK1589","02493","LU0043850808.USD","LU1720050803.USD","BK1576","LU0588546209.SGD","BK1515","LU0140636845.USD","BK0188","LU0856984785.SGD","LU1688375341.USD","LU0516423174.USD","LU0327786744.USD","02269","BK0028","BK1610","LU1880383366.USD","LU0181495838.USD","BK1161","LU0417516738.SGD","LU0823426308.USD","LU3063872942.SGD","LU0052750758.USD","LU0039217434.USD","LU0516423091.SGD","LU0456827905.SGD","LU0823426480.USD","SG9999002463.SGD","LU2039709279.SGD","LU1242518857.USD","LU0516422366.SGD","LU0979878070.USD","LU0572944931.SGD","LU0307460666.USD","LU0348735423.USD","LU0819121731.USD","LU0417516902.SGD","688062","BK0239","SG9999002562.SGD","BK0060","LU0326950275.SGD","LU0456846285.SGD","LU1794554557.SGD","01877","LU0516422440.USD","BK1583","002275","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627328932","title":"2025年A股药企薪酬：药明康德李革年薪3998万，百济神州人均薪酬94万","url":"https://stock-news.laohu8.com/highlight/detail?id=2627328932","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627328932?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:00","pubTimestamp":1776250843,"startTime":"0","endTime":"0","summary":"红星资本局4月15日消息，随着年报季到来，A股已有超120家医药企业披露了2025年经营业绩，其员工薪酬也受到关注。红星资本局根据企业年报、数据统计发现，药明康德（603259.SH；2359.HK）创始人李革以3998万元的年薪暂列药企管理层第一，较第二名高出1800多万元，其连续位列A股管理层薪酬榜首。人均薪酬方面，百济神州达到94.63万元，位居第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153706121691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0039217434.USD","LU0708995583.HKD","LU1997245094.SGD","LU1688375341.USD","LU1934453819.USD","06160","BK1583","LU1808992512.USD","BK1610","159982","LU1720050803.USD","BK4588","LU0456842615.SGD","LU0572944931.SGD","LU1997244956.HKD","LU2328871848.SGD","LU0051755006.USD","02359","LU1719994722.HKD","LU2488822045.USD","399300","LU0516422366.SGD","LU2242644610.SGD","IE00B0JY6N72.USD","LU1979443071.USD","688235","BK1576","LU0348825331.USD","BK4139","02269","LU1046422090.SGD","603259","LU0417516902.SGD","BK1589","BK4526","LU0327786744.USD","ONC","LU2125910500.SGD","LU0307460666.USD","LU0043850808.USD","LU2039709279.SGD","LU0588546209.SGD","LU2495084118.USD","LU1242518857.USD","LU0320764599.SGD","LU0856984785.SGD","SG9999002562.SGD","LU3063872942.SGD","LU1969619763.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627245420","title":"港股概念追踪 | 创新药板块迎政策东风 国办发文健全药品价格形成机制（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2627245420","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627245420?lang=zh_cn&edition=full","pubTime":"2026-04-15 07:16","pubTimestamp":1776208598,"startTime":"0","endTime":"0","summary":"意见从4个方面提出14条举措，包括完善重点环节药品价格政策、推动相关主体发挥药品价格发现作用、引导关键领域药品价格保持合理水平、加强药品价格治理。具体举措包括优化创新药等新上市药品首发价格机制、发挥医保支付标准对药品价格形成的引导作用、健全药品集中带量采购价格形成机制、完善药品挂网价格管理。《意见》发布后，市场普遍认为新政将为医药产业特别是创新药带来发展新契机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","LU2045819591.USD","06978","LU0348735423.USD","LU2242644610.SGD","159992","LU0417516902.SGD","BK1161","BK1141","LU0359202008.SGD","BK1574","LU0823426308.USD","LU1242518931.SGD","LU1046422090.SGD","LU0307460666.USD","LU0039217434.USD","LU2039709279.SGD","BK4585","LU0516423091.SGD","BK1610","LU0043850808.USD","SG9999002463.SGD","LU0140636845.USD","02359","LU0326950275.SGD","VXUS","BK1583","02269","LU0979878070.USD","IE00B0JY6N72.USD","LU0348825331.USD","02315","LU0819121731.USD","LU0516422366.SGD","LU0572944931.SGD","LU0052750758.USD","LU0856984785.SGD","LU0708995583.HKD","06127","LU0327786744.USD","LU0456827905.SGD","LU0320764599.SGD","LU0051755006.USD","LU0516422440.USD","LU0516422952.EUR","BK1589","LU0181495838.USD","LU0588546209.SGD","LU1242518857.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140433994","title":"异动解读 | 药明生物盘中大涨6.18%，大手买入频现推动股价上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=1140433994","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140433994?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:05","pubTimestamp":1776153953,"startTime":"0","endTime":"0","summary":"药明生物今日盘中大涨6.18%，引起了市场的广泛关注。消息面上，该股在交易时段内多次出现大手买入。上午时段，一笔大手买入涉及资金超过900万港元。午后，另一笔大手买入涉及资金超过1000万港元。临近收盘前，再次出现一笔大手买入。这些连续的大额买单显示了市场资金的积极流入，可能反映了部分投资者对公司前景的看好，从而推动了股价在盘中的显著上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108008134","title":"药明生物3月股份变动月报表：股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1108008134","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108008134?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:42","pubTimestamp":1775724138,"startTime":"0","endTime":"0","summary":"药明生物于2026年4月9日披露2026年3月股份变动月报表。根据公告，截至3月31日，法定注册股本仍维持在6,000,000,000股，面值为每股0.000008333333美元，注册股本合计50,000美元，未发生变动。公告由董事陈智胜签署，明确表示所有股份发行及处理均符合相关上市规则及法律规定。公司股本结构在3月末保持稳定，仅因期权行使略有增加。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142172942","title":"异动解读 | CXO概念股强势，机构看好基本面拐点，药明生物盘中大涨6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142172942","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142172942?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:33","pubTimestamp":1774924385,"startTime":"0","endTime":"0","summary":"药明生物(02269)今日盘中大涨6.38%，成为市场关注焦点。消息面上，CXO（医药研发生产外包）概念股今日表现强势，板块内多只个股同步上涨。根据机构分析，在CXO产业持续出清、股价处于相对低位的背景下，本土头部CDMO企业和受益于国内需求复苏的CRO企业正迎来底部投资机会。从财务、需求和供给数据来看，该机构认为CXO行业的基本面拐点已经出现，并有望持续复苏，这提振了市场对整个板块的信心，从而带动了药明生物等个股的股价上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0778},{"period":"3month","weight":-0.1867},{"period":"6month","weight":0.032},{"period":"1year","weight":0.3987},{"period":"ytd","weight":0.0477}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0185},{"period":"3month","weight":-0.0386},{"period":"6month","weight":-0.006},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0017}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.444444,"avgChangeRate":0.001139},{"month":6,"riseRate":0.625,"avgChangeRate":0.064583},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}